Ra Pharmaceuticals, Inc. - 74933V108
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2020
· Q4 2019
Value (USD)
Total reported value ($000)
$1.354B
QoQ value delta ($000)
-$33.52M
(-2.42%)
Implied price effect (QoQ)
+2.29%
Shares
Total shares
28,215,086
QoQ shares delta
-1,359,321
(-4.6%)
Total shares held by funds (by quarter)
Top holders (Q1 2020)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 233,245 | 4,858,260 | 7.37% |
| BAKER BROS. ADVISORS LP | 100,525 | 2,093,839 | 0.62% |
| VANGUARD GROUP INC | 94,582 | 1,970,034 | 0.0% |
| Magnetar Financial LLC | 80,638 | 1,679,600 | 1.94% |
| JPMORGAN CHASE & CO | 79,786 | 1,661,842 | 0.02% |
| STATE STREET CORP | 78,988 | 1,645,236 | 0.01% |
| FARALLON CAPITAL MANAGEMENT LLC | 69,134 | 1,440,000 | 106.07% |
| CNH PARTNERS LLC | 57,153 | 1,190,437 | 1.91% |
| BARCLAYS PLC | 52,660 | 1,096,869 | 0.04% |
| GOLDMAN SACHS GROUP INC | 48,722 | 1,014,822 | 0.02% |
| Pentwater Capital Management LP | 46,987 | 978,700 | 0.78% |
| CITIGROUP INC | 36,243 | 754,909 | 0.03% |
| GABELLI FUNDS LLC | 30,626 | 637,908 | 0.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,673 | 513,937 | 0.01% |
| Alyeska Investment Group, L.P. | 22,258 | 463,613 | 299.21% |
| Allianz Asset Management GmbH | 22,256 | 463,556 | 110.88% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 21,404 | 445,817 | 0.23% |
| NORTHERN TRUST CORP | 19,822 | 412,861 | 0.01% |
| DIMENSIONAL FUND ADVISORS LP | 16,478 | 343,215 | 0.01% |
| BALYASNY ASSET MANAGEMENT LLC | 15,701 | 327,045 | 0.19% |
| MORGAN STANLEY | 15,344 | 319,579 | 0.0% |
| ALLIANCEBERNSTEIN L.P. | 14,894 | 310,218 | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 14,439 | 300,745 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 12,482 | 259,994 | 0.04% |
| MARSHALL WACE, LLP | 11,989 | 249,715 | 0.12% |